Cardiac effects of induction agents in the septic rat heart

Critical Care

Volumn 13, Issue 5, 2009, Pages

  Zausig, York A ^a   Busse, Hendrik ^a   Lunz, Dirk ^a   Sinner, Barbara ^a   Zink, Wolfgang ^a   Graf, Bernhard M ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETOMIDATE; KETAMINE; METHOHEXITAL; MIDAZOLAM; PROPOFOL; ANALGESIC AGENT; INTRAVENOUS ANESTHETIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HEART; HEART LEFT VENTRICLE PRESSURE; HEART RATE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CARDIOMYOPATHY; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; GERMANY; PATHOPHYSIOLOGY; RANDOMIZATION; SEPSIS; WISTAR RAT;

ANALGESICS; ANESTHETICS, INTRAVENOUS; ANIMALS; CARDIOMYOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; GERMANY; HEART; KETAMINE; MALE; METHOHEXITAL; MIDAZOLAM; PROPOFOL; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEPSIS;

EID: 77949901324     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8038     Document Type: Article

References (29)

1. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
2. Reinhart K, Brunkhorst F, Bone H, Gerlach H, Grundling M, Kreymann G, Kujath P, Marggraf G, Mayer K, Meier-Hellmann A, Peckelsen C, Putensen C, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Werdan K. [Diagnosis and therapy of sepsis: guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine]. Anaesthesist 2006, 55(Suppl 1):43-56.
3. Malerba G, Romano-Girard F, Cravoisy A, Dousset B, Nace L, Levy B, Bollaert PE. Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation. Intensive Care Med 2005, 31:388-392.
4. Ray DC, McKeown DW. Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock. Crit Care 2007, 11:R56. 2206408, 17506873.
5. McCollum JS, Dundee JW. Comparison of induction characteristics of four intravenous anaesthetic agents. Anaesthesia 1986, 41:995-1000.
6. Stowe DF, Bosnjak ZJ, Kampine JP. Comparison of etomidate, ketamine, midazolam, propofol, and thiopental on function and metabolism of isolated hearts. Anesth Analg 1992, 74:547-558.
7. Parrillo JE. Myocardial depression during septic shock in humans. Crit Care Med 1990, 18:1183-1184.
8. Muller-Werdan U, Buerke M, Ebelt H, Heinroth KM, Herklotz A, Loppnow H, Russ M, Schlegel F, Schlitt A, Schmidt HB, Schmidt HB, Soffker G, Werdan K. Septic cardiomyopathy - A not yet discovered cardiomyopathy?. Exp Clin Cardiol 2006, 11:226-236. 18651035, 2276158.
9. Fernandes CJ, Akamine N, Knobel E. Myocardial depression in sepsis. Shock 2008, 30(Suppl 1):14-17.
10. Merx MW, Weber C. Sepsis and the heart. Circulation 2007, 116:793-802.
11. Krishnagopalan S, Kumar A, Parrillo JE. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002, 8:376-388.
12. Zink W, Kaess M, Hofer S, Plachky J, Zausig YA, Sinner B, Weigand MA, Fink RH, Graf BM. Alterations in intracellular Ca2+-homeostasis of skeletal muscle fibers during sepsis. Crit Care Med 2008, 36:1559-1563.
13. Zausig YA, Stowe DF, Zink W, Grube C, Martin E, Graf BM. A comparison of three phosphodiesterase type III inhibitors on mechanical and metabolic function in guinea pig isolated hearts. Anesth Analg 2006, 102:1646-1652.
14. Stowe DF, Graf BM, Fujita S, Gross GJ. One-day cold perfusion of bimakalim and butanedione monoxime restores ex situ cardiac function. Am J Physiol 1996, 271:H1884-1892.
15. Heck M, Fresenius M. Repetitorium Anaesthesiologie. 2007, Heidelberg: Springer, 5.
16. Sinner B, Graf BM. Ketamine. Handb Exp Pharmacol 2008, 313-333.
17. Johnson KB, Egan TD, Kern SE, McJames SW, Cluff ML, Pace NL. Influence of hemorrhagic shock followed by crystalloid resuscitation on propofol: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology 2004, 101:647-659.
18. Annane D. ICU physicians should abandon the use of etomidate!. Intensive Care Med 2005, 31:325-326.
19. Absalom A, Pledger D, Kong A. Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia 1999, 54:861-867.
20. Johnson KB, Egan TD, Kern SE, White JL, McJames SW, Syroid N, Whiddon D, Church T. The influence of hemorrhagic shock on propofol: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology 2003, 99:409-420.
21. Shirozu K, Akata T, Yoshino J, Setoguchi H, Morikawa K, Hoka S. The mechanisms of the direct action of etomidate on vascular reactivity in rat mesenteric resistance arteries. Anesth Analg 2009, 108:496-507.
22. Graf BM, Vicenzi MN, Martin E, Bosnjak ZJ, Stowe DF. Ketamine has stereospecific effects in the isolated perfused guinea pig heart. Anesthesiology 1995, 82:1426-1437. discussion 1425A.
23. Sekino N, Endou M, Hajiri E, Okumura F. Nonstereospecific actions of ketamine isomers on the force of contraction, spontaneous beating rate, and Ca2+ current in the guinea pig heart. Anesth Analg 1996, 83:75-80.
24. Hassoun SM, Marechal X, Montaigne D, Bouazza Y, Decoster B, Lancel S, Neviere R. Prevention of endotoxin-induced sarcoplasmic reticulum calcium leak improves mitochondrial and myocardial dysfunction. Crit Care Med 2008, 36:2590-2596.
25. Ren J, Ren BH, Sharma AC. Sepsis-induced depressed contractile function of isolated ventricular myocytes is due to altered calcium transient properties. Shock 2002, 18:285-288.
26. Freise H, Bruckner UB, Spiegel HU. Animal models of sepsis. J Invest Surg 2001, 14:195-212.
27. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW, Bland KI, Chaudry IH. Cecal ligation and puncture. Shock 2005, 24(Suppl 1):52-57.
28. Leibowitz AB. Tracheal intubation in the intensive care unit: extremely hazardous even in the best of hands. Crit Care Med 2006, 34:2497-2498.
29. Graf BM, Abraham I, Eberbach N, Kunst G, Stowe DF, Martin E. Differences in cardiotoxicity of bupivacaine and ropivacaine are the result of physicochemical and stereoselective properties. Anesthesiology 2002, 96:1427-1434.